🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

It’s crazy how talking with a science buddy is simultaneously what’s most likely to move the project forward and the thing that’s least prioritized in our schedule.

EAU Guidelines - Editor's Choice: European Association of Urology Guidelines on Non–muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ)—A Summary of the 2024 Guidelines Update by Paolo Gontero et al Read the full article here: buff.ly/3D92sAx Come back later

I interact with a lot of PhDs looking for jobs in biotech. Something I personally think is poorly predictive of thriving as a professional scientist: whether you were in a winner-take-all authorship position on a research article curated by secret reviewers/editors into some

Bladder cancer care is ⬆️⬆️expensive these days 💸. Costs skyrocket from $200K+ for high-risk NMIBC cases to $100K PER tx in advanced dz .. what’s the solution here ? #BladderCancer European Urology Sarah P. Psutka MD MS Ashish M. Kamat, MD, MBBS sciencedirect.com/science/articl…

This is the most comprehensive integrative omics profiling of >400 NMIBC tumors! A novel integrative clustering defines the iClusters A targetable 'iClus4' with immune exhaustion signature and WGD in most high-grade tumors! Congrats Lars Dyrskjøt and team on another huge milestone!

Big news👋. A positive R3 trial for PD-1 in NMIBC! The CREST trial evaluated sasanlimab (PD-1i)+BCG vs Standard BCG (induction and maintenance) in BCG-naïve, high-risk NMIBC.The study met its primary endpoint of EFS with ‘clinically meaningful’ results. pfizer.com/news/press-rel…

The IBCG Board is excited to announce the new IBCG Center for Patient-Centric Care Initiatives! This global effort will bring together leading experts, patients, and advocates to explore the multifaceted aspects of patient-centric care with a focus on empowering patients,

queensu.ca/gazette/storie…

Immune cell sequencing from birth to old age "Using our lifecycle-wide single-cell dataset covering 13 age groups over the extent of the human lifespan, we established a comprehensive cross-age index (siAge score) as a type of machine-learning-based immune aging clock to

Save the Date for IBCN's Annual Meeting!! Oct. 9-11, 2025 Munich, Germany

Thank you, Roger Roger Li Moffitt Cancer Center for inviting and for the opportunity to discuss our work on B cells and TLSs in bladder cancer Moffitt cancer center, such a happening place with lots of exciting bladder cancer research you are leading…plus the lovely Florida🌞 weather!

M cells in the eyes: Allergen uptake from TALT M cells is a major driver of allergic conjunctivitis mucosalimmunology.org/article/S1933-…

Congrats Girish Kulkarni Nimira Alimohamed on such a successful & amazing 6th Bladderca forum 🇨🇦 with an all ⭐️ faculty covering key basic/translational science & controversial clinical topics across the spectrum. Thanks for the invitation & warm hospitality!

Inspiring panel at the Basic Science Symposium at #AUA25: “Aging in the Urinary Tract—Advancing Research, Advocacy, and Awareness.” Co-chairs Jill Macoska, PhD and Dr. Indira Mysorekar challenged panelists to think beyond their labs, highlighting how basic science, clinical needs, and

And that is a wrap on the AUA-IBCG Bladder Cancer Forum! Thank you to everyone who attended this year and we can’t wait to see you in D.C. next year! IBCG #AUA25

Excited to share my PhD research in Cancer Research and at #AACR2025 which elucidates the non-receptor tyrosine kinase Fes as a novel innate immune checkpoint whose deletion enhances innate immunity and sensitizes ICI-resistant tumours to anti-PD1 blockade! Sinclair Cancer Research Institute Queen's Health Sciences

Truly deserving of this medal for all her contributions in cancer research and support to several trainees and PIs at DBMS and SCRI! Congrats Gwenaelle (not on twitter)!!! Thanks to Terry Fox Research Institute for nominating!

Was an amazing session and a great meeting #AUA25! Aging remains a major 'unmodifiable risk factor' underlying poor outcomes (+/- BCG) in NMIBC. Thanks to Amer. Urol. Assn., for inviting to present our work along the axis of 'immune system aging' and bladder cancer progression!

"Life is the shape it is for a purpose And when you see how things really are all the hurt and the waste falls away What's left is the beauty" Rosalind Franklin, in the "Life Story" movie (1987), especially recommended watching for early career scientists. vimeo.com/179934156?&log…

The most practice changing trial from #ASCO25 is now live on NEJM .If this was a drug, this would be approved today. Globally relevant and low-cost intervention that is not only delaying relapse but actually improving survival. Perfect case example of a #cancergroundshot trial.